发明名称 USE OF CPG OLIGONUCLEOTIDES IN THE TREATMENT OF HEPATITIS C VIRUS INFECTION
摘要 The invention provides methods for identifying and treating subjects having hepatitis C infections. In some instances, the subjects are those that are n on- responsive to non-CpG therapy. Preferably, the subjects are treated with C class CpG immunostimulatory nucleic acids having a semi-soft backbone.</SDOA B>
申请公布号 CA2503693(A1) 申请公布日期 2004.05.13
申请号 CA20032503693 申请日期 2003.10.29
申请人 COLEY PHARMACEUTICAL GROUP, LTD.;COLEY PHARMACEUTICAL GMBH 发明人 DAVIS, HEATHER LYNN;EFLER, SUSAN M.;AHLUWALIA, NAVNEET K.;VOLLMER, JORG
分类号 A61K31/7088;A61K38/21;A61P31/14;G01N33/576;(IPC1-7):A61K38/21;A61K31/708 主分类号 A61K31/7088
代理机构 代理人
主权项
地址